1-18 of 18
Nagesh Kalakonda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Estimates of Survival and Life Expectancy with Tafasitamab Plus Lenalidomide in the L-Mind Study Compared with Real-World Standard-of-Care for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Johannes Duell, Martin Dreyling, Gianluca Gaidano, Nagesh Kalakonda, Eva Maria Gonzalez Barca, Anna Marina Liberati, Zsolt Nagy, Daniel Moik, Mirko Vukcevic, Aasim Amin, Abhishek Bakuli
Journal: Blood
Blood (2023) 142 (Supplement 1): 6286.
https://doi.org/10.1182/blood-2023-174043
Published: 2023
Journal Articles

Deep Immune Profiling Identifies Novel T-Cell Subpopulations That Influence Specific Clinical Outcomes in Chronic Lymphocytic Leukaemia (CLL)

Yeong Jer Lim, Andrew Duckworth, Kim Clarke, Paul Kennedy, Melanie Oates, Matthew Gornall, Nagesh Kalakonda, Joseph Slupsky, Andrew Pettitt
Journal: Blood
Blood (2023) 142 (Supplement 1): 4626.
https://doi.org/10.1182/blood-2023-185091
Published: 2023
Journal Articles

High Dimensional Detection of Non-Malignant B-Cells and Its Clinical Implications in Patients with Chronic Lymphocytic Leukaemia (CLL) Undergoing Frontline Therapy

Yeong Jer Lim, Andrew Duckworth, Kim Clarke, Melanie Oates, Matthew Gornall, Nagesh Kalakonda, Joseph Slupsky, Andrew Pettitt
Journal: Blood
Blood (2023) 142 (Supplement 1): 1894.
https://doi.org/10.1182/blood-2023-185018
Published: 2023
Journal Articles

Immunomodulatory Effects of Chemo-Immunotherapy ± Idelalisib in Chronic Lymphocytic Leukaemia (CLL)

Yeong Jer Lim, Andrew Duckworth, Kim Clarke, Melanie Oates, Matthew Gornall, Nagesh Kalakonda, Joseph Slupsky, Andrew Pettitt
Journal: Blood
Blood (2023) 142 (Supplement 1): 1455.
https://doi.org/10.1182/blood-2023-185063
Published: 2023
Journal Articles

Efficacy of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with High-Risk Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the L-Mind Study

Eva González-Barca, MD PhD, Johannes Duell, MD, Federica Cavallo, Juan-Manuel Sancho, MD PhD, Zsolt Nagy, MD PhD, Pau Abrisqueta, MD PhD, Carlos Panizo, MD PhD, Marinela Augustin, Johannes Weirather, PhD, Sumeet Ambarkhane, MD MBBS, Kami J. Maddocks, MD, Nagesh Kalakonda, MD, Gilles Salles, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-140294
Published: 2020
Journal Articles

Effect of Age on the Efficacy and Safety of Single Agent Oral Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sadal Pivotal Study

Michael W. Schuster, MD, Miguel A Canales, MD PhD, Jason Westin, MD, Josée M Zijlstra, MD PhD, George A Follows, MD PhD, Reem Karmali, MDMSc, Nagesh Kalakonda, MD, Andre H. Goy, MD, Rene-Olivier Casasnovas, MD, Joost Vermaat, MD PhD, Eric Van Den Neste, MD, Sylvain Choquet, MD, Catherine Thieblemont, MD PhD, Federica Cavallo, MD PhD, Maria de Fatima De La Cruz, MD, Brian T. Hill, MD, Herve Tilly, MD PhD, Shireen Kassam, MBBS, FRCPath, PhD, Reda Bouabdallah, MD, Ulrich Jaeger, MD, Ronit Gurion, MD, Paolo Caimi, MD, Peter Martin, FRCPC, MD MS, Andrew Davies, MD PhD, Sonali M. Smith, MD, Graham P. Collins, MD DPhil, Fritz C. Offner, MD PhD, Gilles Salles, MD PhD, Xiwen Ma, Kelly Corona, Jean-Richard Saint-Martin, Anita A. Joshi, Kamal Chamoun, MD, Hongwei Wang, MD PhD, Jatin J. Shah, MD, Sharon Shacham, PhD MBA, Michael G Kauffman, MD PhD, Marie Maerevoet, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5–6.
https://doi.org/10.1182/blood-2020-137020
Published: 2020
Journal Articles

Selinexor Efficacy and Safety Are Independent of Renal Function in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis from the Pivotal Phase 2b Sadal Study

Michael W. Schuster, MD, Miguel A Canales, MD PhD, Jason Westin, MD, Josée M Zijlstra, MD PhD, George A Follows, MD PhD, Reem Karmali, MDMSc, Nagesh Kalakonda, MD, Andre H. Goy, MD, Rene-Olivier Casasnovas, MD, Joost Vermaat, MD PhD, Eric Van Den Neste, MD, Sylvain Choquet, MD, Catherine Thieblemont, MD PhD, Federica Cavallo, MD PhD, Maria de Fatima De La Cruz, MD, Brian T. Hill, MD, Herve Tilly, MD PhD, Shireen Kassam, MBBS, FRCPath, PhD, Reda Bouabdallah, MD, Ulrich Jaeger, MD, Ronit Gurion, MD, Paolo Caimi, MD, Peter Martin, FRCPC, MD MS, Andrew Davies, MD PhD, Sonali M. Smith, MD, Graham P. Collins, MD DPhil, Fritz C. Offner, MD PhD, Gilles Salles, MD PhD, Xiwen Ma, Kelly Corona, Jean-Richard Saint-Martin, Anita A. Joshi, Kamal Chamoun, MD, Hongwei Wang, MD PhD, Jatin J. Shah, MD, Sharon Shacham, PhD MBA, Michael G Kauffman, MD PhD, Marie Maerevoet, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–35.
https://doi.org/10.1182/blood-2020-137025
Published: 2020
Journal Articles

Effect of Prior Therapy on the Efficacy and Safety of Oral Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sadal Study

Federica Cavallo, MD PhD, George A Follows, MD PhD, Andre Goy, MD, Joost Vermaat, MD PhD, Rene-Olivier Casasnovas, MD, Orly Lavee, MD, Marie Maerevoet, MD, Josée M Zijlstra, MD PhD, Sameer Bakhshi, MD, Reda Bouabdallah, Sylvain Choquet, MD, Ronit Gurion, MD, Brian T. Hill, MD, Ulrich Jaeger, MD, Juan-Manuel Sancho, MD PhD, Michael W. Schuster, MD, Catherine Thieblemont, MD PhD, Fatima De la Cruz, MD, Miklos Egyed, MD PhD, Sourav Mishra, Fritz Offner, MD, Theodoros P. Vassilakopoulos, MD PhD, Krzysztof Warzocha, Daniel McCarthy, Xiwen Ma, Kelly Corona, Jean-Richard Saint-Martin, Anita Joshi, PhD, Jatin Shah, MD, Eric Van Den Neste, MD, Miguel A Canales, MD PhD, Nagesh Kalakonda, FRCPath PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5333.
https://doi.org/10.1182/blood-2019-122900
Published: 2019
Journal Articles

Single Agent Oral Selinexor Demonstrates Deep and Durable Responses in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in Both GCB and Non-GCB Subtypes: The Phase 2b Sadal Study

Marie Maerevoet, MD, Joost Vermaat, MD PhD, Miguel A. Canales, René-Olivier Casasnovas, MD, Eric Van Den Neste, Andre Goy, MD, Brian T. Hill, MD PhD, Catherine Thieblemont, MD PhD, Maria De Fatima De La Cruz, Federica Cavallo, MD PhD, George Follows, MD, Sylvain Choquet, MD, Ronit Gurion, MD, Reda Bouabdallah, MD, Ulrich Jaeger, MD, Agnes Nagy, MD, John Kuruvilla, MD, Krzysztof Warzocha, MD, Nagesh Kalakonda, MD, Paolo Caimi, MD, Sameer Bakhshi, MD, Matthew Ku, MBBS, FRACP, FRCPA, Nada Hamad, MD, Hendrik Veelken, MD PhD, Ewa Matczak, MD, Xiwen Ma, Jean-Richard Saint-Martin, Jatin J. Shah, MD, Michael G. Kauffman, MD PhD, Sharon Shacham, PhD MBA, Josée M Zijlstra, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1677.
https://doi.org/10.1182/blood-2018-99-116868
Published: 2018
Journal Articles

Resolution of Peripheral Neuropathy (PN) in Patients Who Received A+AVD or ABVD in the Phase 3 ECHELON-1 Trial

John Radford, MD FRCP, Joseph M. Connors, MD, Anas Younes, MD, Andrea Gallamini, MD, Stephen M. Ansell, MD PhD, Won Seog Kim, MD PhD, Ajay K. Gopal, MD, Mark S Kaminski, MD, June Won Cheong, MDPhD, Ian W. Flinn, MD PhD, Nagesh Kalakonda, MD, Ruth Pettengell, MD, Monika Dlugosz-Danecka, MD PhD, Gerald Engley, PharmD, Keenan Fenton, Rachael Liu, PhD, Indra Purevjal, Harry Miao, MD, Ashish Gautam, PhD MBA, John Kuruvilla, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2921.
https://doi.org/10.1182/blood-2018-99-111893
Published: 2018
Journal Articles

Single-Arm Phase II Study of MOR208 Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: L-Mind

Gilles Andre Salles, Johannes Duell, MD, Eva González-Barca, MD PhD, Wojciech Jurczak, MDPhD, Anna Marina Liberati, MD, Zsolt Nagy, MD PhD, Aleš Obr, MD, Gianluca Gaidano, MD PhD, Marc Andre, MDPhD, Nagesh Kalakonda, MD, Martin Dreyling, MD PhD, Pier Luigi Zinzani, MD, Maren Dirnberger-Hertweck, PhD, Johannes Weirather, PhD, Sumeet Ambarkhane, MD MBBS, Kami J. Maddocks, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 227.
https://doi.org/10.1182/blood-2018-99-113399
Published: 2018
Journal Articles

Single-Arm Phase II Study of MOR208 Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: L-Mind

Gilles Andre Salles, MD PhD, Johannes Duell, MD, Eva González-Barca, MD PhD, Wojciech Jurczak, PhDMD, Anna Marina Liberati, MD, Zsolt Nagy, MD PhD, Tomáš Papajik, MD PhD, Gianluca Gaidano, MD PhD, Marc Andre, MD, Nagesh Kalakonda, MD, Martin Dreyling, MD PhD, Pier Luigi Zinzani, MD, Sumeet Ambarkhane, MD, Johannes Weirather, PhD, Maren Dirnberger-Hertweck, PhD, Kami J. Maddocks, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4123.
https://doi.org/10.1182/blood.V130.Suppl_1.4123.4123
Published: 2017
Journal Articles

CC-122 Has Robust Anti-Proliferative Activity in a Primary Chronic Lymphocytic Leukemia (CLL) Co-Culture Model and Is Superior to Lenalidomide

Jemma Blocksidge, Mark Glenn, Anita K. Gandhi, PhD, Anke Klippel, PhD, Michael Pourdehnad, MD, Rajesh Chopra, MD PhD, Nagesh Kalakonda
Journal: Blood
Blood (2014) 124 (21): 4682.
https://doi.org/10.1182/blood.V124.21.4682.4682
Published: 2014
Journal Articles

Variable induction of PRDM1 and differentiation in chronic lymphocytic leukemia is associated with anergy

Andrew Duckworth, Mark Glenn, Joseph R. Slupsky, Graham Packham, Nagesh Kalakonda
Journal: Blood
Blood (2014) 123 (21): 3277–3285.
https://doi.org/10.1182/blood-2013-11-539049
Published: 2014
Includes: Supplemental data
Journal Articles

Insights Into the Differential Induction of PRDM1 in CLL Cells: Relevance for Pathobiology and Disease Therapeutics

Andrew Duckworth, BSc PhD, Mark Glenn, BSc PhD, John C. Cawley, MD, PhD, FRCP, FRCPath, Nagesh Kalakonda, MBBS, MRCP, FRCPath, PhD
Journal: Blood
Blood (2011) 118 (21): 1763.
https://doi.org/10.1182/blood.V118.21.1763.1763
Published: 2011
Journal Articles

Depletion of L3MBTL1, a PcG Gene Deleted in Patients with 20q-Associated with Hematologic Malignancies, Accelerates Erythroid Differentiation of Hematopoietic Progenitor Cells

Fabiana Perna, Nadia Gurvich, Ruben Hoya-Arias, Francesca Voza, Vladimir Jankovic, Nagesh Kalakonda, Stephen D. Nimer
Journal: Blood
Blood (2008) 112 (11): 3740.
https://doi.org/10.1182/blood.V112.11.3740.3740
Published: 2008
Journal Articles

Melphalan-mobilized blood stem cell components contain minimal clonotypic myeloma cell contamination

Clinical Trials & Observations Brief Report
Ping Zhou, Yana Zhang, Carmen Martinez, Nagesh Kalakonda, Stephen D. Nimer, Raymond L. Comenzo
Journal: Blood
Blood (2003) 102 (2): 477–479.
https://doi.org/10.1182/blood-2002-12-3674
Published: 2003
Journal Articles

Detection of N-Ras codon 61 mutations in subpopulations of tumor cells in multiple myeloma at presentation: Presented in part in abstract form at the 40th Annual Meeting of the American Society of Hematology, Miami Beach, FL, December 4-8, 1998; and at the 41st Annual Meeting of the American Society of Hematology, New Orleans, LA, December 3-7, 1999. 32 33

Nagesh Kalakonda, Dominic G. Rothwell, J. Howard Scarffe, John D. Norton
Journal: Blood
Blood (2001) 98 (5): 1555–1560.
https://doi.org/10.1182/blood.V98.5.1555
Published: 2001